Adagene (ADAG) Accumulated Expenses (2019 - 2025)
Adagene's (ADAG) quarterly Accumulated Expenses came in at $2790.8 billion in Q4 2025, down 0.9% year-on-year from $2816.0 billion in Q4 2024, and up 75913576.7% on a QoQ basis from $3.7 million in Q2 2025.
Adagene (ADAG) Accumulated Expenses (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Accumulated Expenses data on file, last reported at $2790.8 billion in Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 0.9% year-over-year to $2790.8 billion in Q4 2025; TTM through Dec 2025 was $2790.8 billion, a 0.9% decrease from a year earlier, with the FY2025 full-year figure at $2790.8 billion, down 0.9% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $2790.8 billion, up from $3.7 million in the prior quarter.
- Over the last five years, Accumulated Expenses for ADAG reached as high as $4237.6 billion in Q2 2022 and fell as low as $2.7 million in Q2 2024.
- Historically, Accumulated Expenses has averaged $1889.3 billion across 5 years, with a median of $2803.4 billion in 2024.
- Across the five-year window, Accumulated Expenses surged 119089996.15% in 2022 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Accumulated Expenses stood at $4.4 million in 2021, then surged by 73364383.31% to $3212.8 billion in 2022, then decreased by 6.58% to $3001.5 billion in 2023, then slipped by 6.18% to $2816.0 billion in 2024, then decreased by 0.9% to $2790.8 billion in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $2790.8 billion in Q4 2025, $3.7 million in Q2 2025, and $2816.0 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,790.79 Bn |
| Jun 30, 2025 | 3.68 Mn |
| Dec 31, 2024 | 2,816.04 Bn |
| Jun 30, 2024 | 2.66 Mn |
| Dec 31, 2023 | 3,001.51 Bn |
| Jun 30, 2023 | 2,834.57 Bn |
| Dec 31, 2022 | 3,212.81 Bn |
| Jun 30, 2022 | 4,237.62 Bn |
| Dec 31, 2021 | 4.38 Mn |
| Jun 30, 2021 | 3.56 Mn |
| Dec 31, 2020 | 6.06 Mn |
| Dec 31, 2019 | 2.54 Mn |